J&J launches final study of COVID-19 vaccine
Johnson & Johnson said it would begin a final 60,000-person trial of a single-shot COVID-19 vaccine, which could prove easier to administer than rivals that require two inoculations.
Subscribe to:
Post Comments (Atom)
Comments
Post a Comment
Leave a comment. Thanks!
Comentarios de Facebook